MAIT Engagers: Potent & Safer Immune Cell Engagers to Treat Solid Tumors
Time: 3:45 pm
day: Day 2
Details:
- Improving the safety profile of T-cell engagers by selectively targeting MAIT cells
- MAIT engagers do not activate regulatory T-cells and restrict cytokine release
- Leveraging human ex vivo data (tumour / organoids) to demonstrate the potential to
- treat cancer
